CPT code 86826: HLA crossmatch, additional sample or dilution2026 Medicare lab fee · Clinical Laboratory Fee Schedule
Reports an additional serum sample or dilution tested in a noncytotoxic HLA crossmatch for organ transplant compatibility.
Medicare pays $36.53 for 86826 under the 2026 Clinical Laboratory Fee Schedule: one national amount, the same in every state and setting.
Medicare lab fee · CLFS 2026 Q4
National CLFS amount
$36.53
In effect since Jan 1, 2026. The same amount in every state, payment locality and setting.
- Geographic adjustment
- None
- Office vs facility
- Same
- Since 2020
- Unchanged
- CMS updates
- Quarterly
Medicare pays the lesser of the lab’s charge and this amount. Patients usually owe no Part B deductible or coinsurance for covered clinical lab tests.
On this page 8 sections
What 86826 covers
This add-on reports a further recipient serum sample or dilution tested as part of a noncytotoxic human leukocyte antigen (HLA) crossmatch. The test assesses whether antibodies in the recipient’s serum react with donor cells, helping transplant teams evaluate immunologic compatibility. Histocompatibility laboratories perform the analysis, often for transplant programs assessing a potential donor-recipient match. The noncytotoxic method may use flow cytometry.
Report 86826 for each additional serum sample or sample dilution, in addition to the primary noncytotoxic crossmatch code 86825. Medicare pays the service only under the Clinical Laboratory Fee Schedule (CLFS). The 2026 national CLFS amount is $36.53, unchanged since 2020; the same amount applies across states and localities, without an office-versus-facility difference. The physician fee schedule excludes this test by statute, so payment is through the CLFS.
This summary was written with AI assistance from CMS Clinical Laboratory Fee Schedule data. Amounts on this page come directly from CMS files.
How Medicare pays 86826
Clinical lab tests aren’t priced like physician services. They’re paid from their own fee schedule, with its own rules. See the whole lab fee schedule.
One national amount
CMS sets a single Clinical Laboratory Fee Schedule amount for 86826. There’s no geographic (GPCI) adjustment, so it pays the same in every state and payment locality.
No office or facility rate
Lab tests aren’t built from relative value units, so there’s no office and facility split: the place of service doesn’t change the CLFS amount.
Updated every quarter
CMS republishes the CLFS each quarter. New tests, often proprietary laboratory analyses (PLA codes), join during the year; existing amounts are updated each January.
Excluded from the physician fee schedule
The physician fee schedule lists 86826 with status X (excluded by statute), so the test itself is paid only from the CLFS.
86826 on the lab fee schedule since 2020
86826 · CLFS 2026 Q4 (current)
$36.53
Unchanged since Jan 1, 2020
27 quarterly CLFS releases on file, first CLFS 2020 Q1. A code missing from a quarter wasn’t on that release.
86826 compared with similar tests
- 86825HLA crossmatchFirst serum sample or dilution$109.49
- 86825 reports the primary noncytotoxic HLA crossmatch. Choose 86826 only for an additional serum sample or sample dilution tested in that crossmatch.
- 86805Lymphocytotoxicity assayVisual crossmatch with titration$189.51
- 86805 describes cytotoxic lymphocytotoxicity testing. Use 86826 for an additional sample or dilution in a noncytotoxic HLA crossmatch.
- 86806Lymphocytotoxicity assayVisual, without titration$47.59
- 86806 is also a cytotoxic lymphocytotoxicity assay, not an additional-sample code for a noncytotoxic crossmatch.
86826 billing questions
When should 86826 be reported instead of 86825?
Use 86825 for the primary noncytotoxic HLA crossmatch. Report 86826 for each additional serum sample or sample dilution tested as part of that crossmatch.
How many units of 86826 should be reported?
Report one unit for each additional serum sample or sample dilution tested. The code is reported in addition to the primary crossmatch service.
How does 86826 differ from a cytotoxic lymphocytotoxicity assay?
86826 is for an additional sample or dilution in a noncytotoxic HLA crossmatch. Codes 86805 and 86806 describe cytotoxic lymphocytotoxicity testing.
Is a physician interpretation separately payable?
Medicare pays 86826 through the CLFS only; the physician fee schedule excludes the test by statute.
Does the Medicare CLFS amount vary by locality or setting?
No. Medicare uses one national amount for this code across states and localities, with no office-versus-facility difference.
Where this amount comes from
FeeBase reads lab amounts directly from the CMS Clinical Laboratory Fee Schedule file for the quarter: one row per code, with its payment indicator and national amount. Contractor-priced tests are labeled, never given a made-up amount. Amounts are Medicare payment limits, not a patient’s bill or a commercial rate.
CMS CLFS 2026 Q4 · effective Oct 1, 2026 through the day before Jan 1, 2027
Show the CMS file line behind this amount
Fee sheets · Coming soon
Put 86826 and the rest of your codes on one sheet
Your codes at your locality, with payer contracts beside Medicare.
Join the waitlist